IDARUCIZUMAB

1434 reported adverse events

Drug classes: Humanized Monoclonal Antibody Fragment [EPC]

These side effects are most commonly reported by patients taking IDARUCIZUMAB:

# Side effect Count
0 DEATH 170
1 HAEMORRHAGE 119
2 GASTROINTESTINAL HAEMORRHAGE 81
3 CEREBRAL HAEMORRHAGE 80
4 HAEMORRHAGE INTRACRANIAL 67
5 DRUG INEFFECTIVE 64
6 MULTIPLE ORGAN DYSFUNCTION SYNDROME 62
7 ACUTE KIDNEY INJURY 48
8 SEPSIS 46
9 ISCHAEMIC STROKE 45
See all common reactions for IDARUCIZUMAB

IDARUCIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COAGULATION FACTOR INCREASED 5 0.0820
1 THROMBIN TIME ABNORMAL 3 0.0667
2 ANTICOAGULATION DRUG LEVEL INCREASED 11 0.0343
3 BASILAR ARTERY OCCLUSION 5 0.0301
4 THROMBIN TIME PROLONGED 6 0.0243
5 POSTOPERATIVE RESPIRATORY FAILURE 2 0.0192
6 STROKE IN EVOLUTION 4 0.0180
7 HAEMORRHAGIC TRANSFORMATION STROKE 26 0.0173
8 QUADRANTANOPIA 2 0.0153
9 ANTICOAGULATION DRUG LEVEL ABNORMAL 2 0.0134
See all enriched reactions for IDARUCIZUMAB